Evidence poor for link between biomarkers and risk of CV events for patients with kidney disease
Even though clinical practice guidelines for patients with chronic kidney disease recommend specific treatment target levels for serum phosphorus, parathyroid hormone, and calcium to reduce the risk of cardiovascular events, ...
